Nabriva Therapeutics Eulerpool Ziņas

Nabriva Therapeutics Akciju Ziņas

Nabriva Therapeutics tiek uzmanīgi vēroti no žurnālistu un investoru puses visā pasaulē. Jaunākās Nabriva Therapeutics ziņas mēs apkopojam šeit.

• 8. marts ·

  CNBC
  Leadership or loneliness? Making sense of why executives are eager to get employees back in the office
• 4. marts ·

  CNBC
  Disney+ to launch cheaper ad-supported tier later this year
• 1. marts ·

  Yahoo
  Nabriva Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
• 29. janvāris ·

  CNBC
  Streaming video no longer impresses investors, so media companies need a next act
• 28. janvāris ·

  CNBC
  Appeals court upholds California's right to enforce its net neutrality law while the FCC remains at a standstill
• 27. janvāris ·

  CNBC
  Ackman takes a big stake in Netflix, excited about company's long-term prospects
• 24. janvāris ·

  CNBC
  Stocks making the biggest moves in the premarket: Kohl's, Snap, Peloton and more
• 20. janvāris ·

  CNBC
  Netflix quietly admits streaming competition is eating into growth
• 18. janvāris ·

  CNBC
  Microsoft's $68.7 billion deal for Activision once again shows big tech's dominance over legacy media
• 14. janvāris ·

  Nasdaq
  Nabriva Therapeutics Plc Shares Close in on 52-Week Low - Market Mover